These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

855 related items for PubMed ID: 17149753

  • 1. Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.
    Mao PX, Tang YL, Jiang F, Shu L, Gu X, Li M, Qian M, Ma C, Mitchell PB, Cai ZJ.
    Depress Anxiety; 2008; 25(1):46-54. PubMed ID: 17149753
    [Abstract] [Full Text] [Related]

  • 2. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
    Azorin JM, Llorca PM, Despiegel N, Verpillat P.
    Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
    [Abstract] [Full Text] [Related]

  • 3. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
    Burke WJ, Gergel I, Bose A.
    J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
    [Abstract] [Full Text] [Related]

  • 4. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ, Jiang Q.
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [Abstract] [Full Text] [Related]

  • 5. [Escitalopram for treatment of major depressive disorder in adults].
    Llorca PM, Brousse G, Schwan R.
    Encephale; 2005 May; 31(4 Pt 1):490-501. PubMed ID: 16389716
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH, Andersen HF, Lam RW.
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [Abstract] [Full Text] [Related]

  • 7. A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder.
    Baldwin DS, Cooper JA, Huusom AK, Hindmarch I.
    Int Clin Psychopharmacol; 2006 May; 21(3):159-69. PubMed ID: 16528138
    [Abstract] [Full Text] [Related]

  • 8. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.
    Bielski RJ, Ventura D, Chang CC.
    J Clin Psychiatry; 2004 Sep; 65(9):1190-6. PubMed ID: 15367045
    [Abstract] [Full Text] [Related]

  • 9. Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence.
    Muhonen LH, Lönnqvist J, Juva K, Alho H.
    J Clin Psychiatry; 2008 Mar; 69(3):392-9. PubMed ID: 18348597
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 11. Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial.
    Kornstein SG, Bose A, Li D, Saikali KG, Gandhi C.
    J Clin Psychiatry; 2006 Nov; 67(11):1767-75. PubMed ID: 17196058
    [Abstract] [Full Text] [Related]

  • 12. Hypoactive sexual desire among depressed female patients treated with selective serotonin reuptake inhibitors: a comparison between escitalopram and fluoxetine.
    Sidi H, Asmidar D, Hod R, Jaafar NR, Guan NC.
    Int J Psychiatry Clin Pract; 2012 Mar; 16(1):41-7. PubMed ID: 22122658
    [Abstract] [Full Text] [Related]

  • 13. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
    Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG.
    J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
    [Abstract] [Full Text] [Related]

  • 14. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
    Olié JP, Gourion D, Montagne A, Rostin M, Poirier MF.
    Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
    [Abstract] [Full Text] [Related]

  • 15. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
    Appelberg BG, Syvälahti EK, Koskinen TE, Mehtonen OP, Muhonen TT, Naukkarinen HH.
    J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
    [Abstract] [Full Text] [Related]

  • 16. Escitalopram in the treatment of depressed elderly patients.
    Kasper S, de Swart H, Friis Andersen H.
    Am J Geriatr Psychiatry; 2005 Oct; 13(10):884-91. PubMed ID: 16223967
    [Abstract] [Full Text] [Related]

  • 17. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Khan A, Bose A, Alexopoulos GS, Gommoll C, Li D, Gandhi C.
    Clin Drug Investig; 2007 Oct; 27(7):481-92. PubMed ID: 17563128
    [Abstract] [Full Text] [Related]

  • 18. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J, Goa KL.
    CNS Drugs; 2003 Oct; 17(5):343-62. PubMed ID: 12665392
    [Abstract] [Full Text] [Related]

  • 19. Escitalopram versus SNRI antidepressants in the acute treatment of major depressive disorder: integrative analysis of four double-blind, randomized clinical trials.
    Kornstein SG, Li D, Mao Y, Larsson S, Andersen HF, Papakostas GI.
    CNS Spectr; 2009 Jun; 14(6):326-33. PubMed ID: 19668123
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of escitalopram in treatment of severe depression in Chinese population.
    Si T, Wang G, Yang F, Fang Y, Fang M, Li J, Dong J, Shen X, Zhuo J, Rui Q, Wang J, Cuili H.
    Metab Brain Dis; 2017 Jun; 32(3):891-901. PubMed ID: 28299626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.